Study on the regularity of the occurrence of acute myocardial infarction based on the five yun and six qi theory and circadian genes

注册号:

Registration number:

ITMCTR2100004515

最近更新日期:

Date of Last Refreshed on:

2021-03-04

注册时间:

Date of Registration:

2021-03-04

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

基于运气学说和生物钟基因探索急性心梗发病时间的规律研究

Public title:

Study on the regularity of the occurrence of acute myocardial infarction based on the five yun and six qi theory and circadian genes

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于运气学说和生物钟基因探索急性心梗发病时间的规律研究

Scientific title:

Study on the regularity of the occurrence of acute myocardial infarction based on the five yun and six qi theory and circadian genes

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2100043871 ; ChiMCTR2100004515

申请注册联系人:

赵静

研究负责人:

沈晓旭

Applicant:

Zhao Jing

Study leader:

Shen Xiaoxu

申请注册联系人电话:

Applicant telephone:

+86 15901281529

研究负责人电话:

Study leader's telephone:

+86 18810956732

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zhaojingyisheng@163.com

研究负责人电子邮件:

Study leader's E-mail:

shenxiaoxupaper@sina.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

北京市东城区海运仓5号

研究负责人通讯地址:

北京市东城区海运仓5号

Applicant address:

5 Haiyuncang, Dongcheng District, Beijing, China

Study leader's address:

5 Haiyuncang, Dongcheng District, Beijing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京中医药大学东直门医院

Applicant's institution:

Dongzhimen Hospital, Beijing University of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2021DZMEC-019-02

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

北京中医药大学东直门医院医学伦理委员会

Name of the ethic committee:

Ethics Committee of Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2021/2/22 0:00:00

伦理委员会联系人:

韩雪婷

Contact Name of the ethic committee:

Han Xueting

伦理委员会联系地址:

北京市东城区海运仓5号

Contact Address of the ethic committee:

5 Haiyuncang, Dongcheng District, Beijing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

北京中医药大学东直门医院

Primary sponsor:

Dongzhimen Hospital, Beijing University of Chinese Medicine

研究实施负责(组长)单位地址:

北京市东城区海运仓5号

Primary sponsor's address:

5 Haiyuncang, Dongcheng District, Beijing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京中医药大学东直门医院

具体地址:

东城区海运仓5号

Institution
hospital:

Dongzhimen Hospital, Beijing University of Chinese Medicine

Address:

5 Haiyuncang, Dongcheng District

经费或物资来源:

国家重点研发计划

Source(s) of funding:

the National Key Research and Development Program of China

研究疾病:

急性心肌梗死

研究疾病代码:

Target disease:

acute myocardial infarction

Target disease code:

研究类型:

Study type:

观察性研究

Observational study

研究设计:

Study design:

连续入组

Sequential

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

探讨褪黑素水平与生物钟基因水平的关联,以及这些指标与心梗发病时间点的相关性,以期为临床上预测急性心肌梗死的发病时间提供思路

Objectives of Study:

Objective to explore the association between melatonin level and circadian genes level, and the correlation between these indicators and the occurrence of myocardial infarction, so as to provide ideas for clinical prediction of the occurrence of acute myocardial infarction.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

①急性心肌梗死组: 符合急性心肌梗死诊断标准并确诊者; ②非冠心病组: 既往无冠心病诊断史,无典型缺血性心前区疼痛症状,心电图无缺血相关改变; ③年龄在 45 周岁-65 周岁; ④生源地及久居地为北京市; ⑤自愿参加试验,签署知情同意书者。

Inclusion criteria

1. Acute myocardial infarction group: those who met the diagnostic criteria of acute myocardial infarction and were diagnosed; 2. Non coronary heart disease group: no previous diagnosis of coronary heart disease 3. Aged from 45 to 65 years; 4. The place of origin and permanent residence is Beijing; 5. Those who voluntarily participated in the trial and signed the informed consent.

排除标准:

①主动脉夹层、肺动脉栓塞、原发性心肌病; ②有恶性肿瘤; ③合并严重感染者,如:严重的肺部感染等; ④有血液系统疾病者; ⑤现合并能引起体内激素变化的疾病,如:垂体瘤、库欣综合征、肾上腺瘤等; ⑥服用抗精神类药物或有精神疾病史者; ⑦合并糖尿病患者; ⑧妊娠或哺乳期妇女,以及诊断为更年期综合征妇女; ⑨肝功能不全者(谷丙转氨酶、谷草转氨酶升高正常值 2 倍以上); ⑩肾功能不全者(血清肌酐升高正常值 1.5 倍以上)。

Exclusion criteria:

1. Aortic dissection, pulmonary embolism, primary cardiomyopathy; 2. There were malignant tumors; 3. Patients with severe infection, such as severe pulmonary infection; 4. Patients with hematological diseases; 5. Some diseases can cause hormone changes in the body, such as pituitary adenoma, Cushing's syndrome and adrenal adenoma Etc; 6. Taking antipsychotics or having a history of mental illness; 7. Patients with diabetes; 8. Pregnant or lactating women, and women diagnosed with climacteric syndrome; 9. Patients with liver dysfunction; 10. Patients with renal insufficiency.

研究实施时间:

Study execute time:

From 2021-03-01

To      2022-02-21

征募观察对象时间:

Recruiting time:

From 2021-03-01

To      2022-01-01

干预措施:

Interventions:

组别:

观察性研究

样本量:

60

Group:

observational study

Sample size:

干预措施:

N/A

干预措施代码:

N/A

Intervention:

N/A

Intervention code:

样本总量 Total sample size : 60

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

东直门医院

单位级别:

三甲

Institution/hospital:

Dongzhimen Hospital, Beijing University of Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

生物钟基因水平

指标类型:

次要指标

Outcome:

circadian gene level

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心梗发作时间点

指标类型:

主要指标

Outcome:

the occurrence of acute myocardial infarction

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

外周血的褪黑素水平

指标类型:

次要指标

Outcome:

Melatonin levels

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小
Min age years
最大
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

非随机对照试验

Randomization Procedure (please state who generates the random number sequence and by what method):

Non-randomized controlled trial.

盲法:

N/A

Blinding:

N/A

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

共享日期为本研究论文发表后; EXCEL 请阅读网页注册指南中关于 原始数据共享 的内容。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The date will be shared after the publication of this research paper; EXCEL

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集:采用统一的纸质病例报告表;数据录入:用SPSS软件

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection: using a unified paper case report form;data entry:using SPSS software

数据管理委员会:

Data Managemen Committee:

No

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above